SELLAS Life Sciences Group Inc —— 季度财务数据 (NASDAQ:SLS) | MetaTrader

展开完整图表

Financials

概览声明统计股息

每季度年度

经营活动产生的现金 -7.15 M-9.07 M-7.33 M-7.07 M-4.92 M -28.39 M 投资活动产生的现金 0———— — 融资活动产生的现金 8 00023.58 M4.23 M26.09 M32.39 M 86.3 M 自由现金流 -7.15 M-9.07 M-7.33 M-7.07 M-4.92 M -28.39 M

新闻

SELLAS在SLS009二期急性髓系白血病试验中完成首例患者入组

SELLAS enrolls first patient in Phase 2 AML trial of SLS009

Sellas Life Sciences报告权证行权收益达4260万美元

Sellas Life Sciences reports $42.6 million in warrant exercise proceeds

What's Going With SELLAS Life Sciences Stock On Wednesday? - SELLAS Life Sciences Gr (NASDAQ:SLS)

H.C. Wainwright上调Solaris Resources目标价至16美元，看好Warintza项目进展

H.C. Wainwright raises Solaris Resources stock price target to $16 on Warintza progress

Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS)

Solaris Resources股票创52周新高，达到$8.54

SELLAS与IMPACT-AML合作开展欧洲SLS009临床试验

SELLAS partners with IMPACT-AML for European SLS009 trials

Lam Research, Micron Tech among market cap stock movers on Tuesday